Research Topics
| Marvin A KonstamSummaryAffiliation: Tufts-New England Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failureMarvin A Konstam
Tufts New England Medical Center, Tufts University, Boston, MA, USA
Circulation 112:3107-14. 2005....
Endothelin expression and the progression of heart failure: exemplifying the vagaries of therapeutic developmentMarvin A Konstam
Division of Cardiology, Department of Medicine, Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Mass, USA
Circulation 109:143-5. 2004
Aspirin and heart failure: square evidence meets a round patientMarvin A Konstam
Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA
Congest Heart Fail 9:203-5. 2003
Heart failure training: a call for an integrative, patient-focused approach to an emerging cardiology subspecialtyMarvin A Konstam
Division of Cardiology, Department of Medicine, Tufts New England Medical Center, 750 Washington Street, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 44:1361-2. 2004....
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome TrialMarvin A Konstam
Division of Cardiology, Tufts New England Medical Center, Boston, Mass, USA
JAMA 297:1319-31. 2007..Vasopressin mediates fluid retention in heart failure. Tolvaptan, a vasopressin V2 receptor blocker, shows promise for management of heart failure...
Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II)Marvin A Konstam
Division of Cardiology, Tufts New England Medical Center, Boston, MA 02111, USA
Am Heart J 150:123-31. 2005..We compared effects of losartan to captopril on mortality, morbidity, and functional status for patients in the ELITE II study...
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)Mihai Gheorghiade
Division of Cardiology, Northwestern Feinberg School of Medicine, Chicago, IL, USA
J Card Fail 11:260-9. 2005..The results of EVEREST will determine whether these effects translate into improved clinical outcomes...
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status TrialsMihai Gheorghiade
Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA
JAMA 297:1332-43. 2007..Heart failure causes more than 1 million US hospitalizations yearly, mostly related to congestion. Tolvaptan, an oral, nonpeptide, selective vasopressin V2-receptor antagonist, shows promise in this condition...
Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trialCarey Kimmelstiel
Division of Cardiology, Tufts-New England Medical Center, and Tufts University School of Medicine, Boston, Mass 02111, USA
Circulation 110:1450-5. 2004..Longer-term benefit likely requires more active chronic intervention, even among patients who appear clinically stable...
Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trialJames E Udelson
Division of Cardiology, Tufts Medical Center, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 52:1540-5. 2008..This study sought to assess the acute hemodynamic effect of vasopressin V(2) receptor antagonism...
Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunctionAlawi A Alsheikh-Ali
Tufts-New England Medical Center, Department of Medicine, Division of Cardiolgy, Boston, Mass, USA
Am Heart J 147:1061-5. 2004..4 per 1000 patient-years in the placebo group (RR, 0.64; 95% CI, 0.48-0.85; P =.002). CONCLUSION: Enalapril is associated with a decreased incidence of hospitalization with atrial tachyarrhythmias in patients with LV dysfunction...
Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heartRichard D Patten
Molecular Cardiology Research Institute, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 45:1419-24. 2005..We examined the effect of mechanical unloading with ventricular assist device (VAD) therapy on myocardial inducible nitric oxide synthase (iNOS) expression and cardiomyocyte apoptosis in patients with end-stage heart failure (HF)...
Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trialDouglas Gregory
Cardiovascular Clinical Studies, Boston, MA 02111, USA
Am Heart J 151:1013-8. 2006..Determine the effect on hospitalization cost of a heart failure disease management (HFDM) program delivered within a diverse provider network as demonstrated in the SPAN-CHF randomized controlled trial...
Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunctionJames E Udelson
Division of Cardiology, Tufts New England Medical Center Tufts University School of Medicine, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 49:2151-9. 2007..This study sought to examine the effects of vasopressin V2 receptor antagonism with tolvaptan on the changes in left ventricular (LV) volumes over time...
New concepts in post-infarction ventricular remodelingJames E Udelson
Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
Rev Cardiovasc Med 4:S3-12. 2003..It is also demonstrated that drug therapies that slow or reverse the remodeling process appear to have favorable natural history effects in the short term as well as during long-term therapy...
Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunctionJames E Udelson
Tufts Medical Center, 750 Washington Street, Boston, MA 02111, USA
Circ Heart Fail 3:347-53. 2010..Few data are available on effects of aldosterone antagonism in patients with mild-to-moderate HF...
Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouseRichard D Patten
Molecular Cardiology Research Institute, New England Medical Center, 750 Washington Street, Boston, MA 02111, USA
Clin Sci (Lond) 104:109-18. 2003..These results serve as an important basis for planned investigations to evaluate the anti-remodelling effects of these agents on mice in which genetic manipulations are used to disrupt components of the Ang II signalling system...
Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunctionJames E Udelson
Division of Cardiology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA, USA
J Card Fail 8:S465-71. 2002....
The economic effect of a tertiary hospital-based heart failure programDouglas Gregory
Cardiovascular Clinical Studies and Tufts University School of Medicine, Boston, Massachusetts, USA
J Am Coll Cardiol 46:660-6. 2005..This study was designed to determine the economic effect of a tertiary heart failure (HF) program at an academic medical center...
Peripheral vascular endothelial function correlates with exercise capacity in cardiac transplant recipientsAyan R Patel
Division of Cardiology/Department of Medicine, Molecular Cardiology Research Institute, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Am J Cardiol 91:897-9. 2003
Improving clinical outcomes with drug treatment in heart failure: what have trials taught?Marvin A Konstam
Department of Medicine, Division of Cardiology, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
Am J Cardiol 91:9D-14D. 2003..Clinical trials have provided significant treatment advances; ongoing and future trials will demonstrate the degree to which we can improve on what we have achieved to date with pharmacologic treatments...
Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approachDaniel G Kramer
Division of Cardiology and the CardioVascular Center, Tufts Medical Center, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 56:392-406. 2010..The purpose of this study was to quantitatively assess the relationship between therapy-induced changes in left ventricular (LV) remodeling and longer-term outcomes in patients with left ventricular dysfunction (LVD)...
Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunctionDouglas D Gregory
Division of Clinical Decision Making, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
Am J Cardiol 92:1300-5. 2003....
Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptorPaul Bridgman
Molecular Cardiology Research Institute, Tufts New England Medical Center, Box 80, 750 Washington St, Boston, MA 02111, USA
Am J Physiol Heart Circ Physiol 289:H586-92. 2005..Further work is necessary to explore the potential mechanisms underlying these gender-based differences...
Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trialJohn E A Blair
Division of Cardiology, Northwestern University Feinberg School of Medicine, 676 North Saint Clair, Suite 600, Chicago, IL 60611, USA
Eur Heart J 30:1666-73. 2009..We explore the relationship between change in BW after hospitalization for worsening HF and risk for repeat hospitalization and mortality in the EVEREST trial...
Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitorMarvin A Konstam
Tufts Medical Center, Boston, MA 02111, USA
Eur J Heart Fail 10:899-906. 2008....
Comparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus those not taking amiodaronePatrick J Blomberg
Division of Cardiology, Tufts University Medical School, Tufts-New England Medical Center, Boston, Massachusetts, USA
Am J Cardiol 93:379-81. 2004..These findings raise further concern about the use of amiodarone treatment in patients with heart failure before undergoing HT...
The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registryVishnu Patlolla
Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
J Am Coll Cardiol 53:264-71. 2009..This study sought to determine the relationship between pre-transplant ventricular assist device (VAD) support and mortality after heart transplantation...
Contemporary medical options for treating patients with heart failureMarvin A Konstam
Department of Medicine, Division of Cardiology, Tufts-New England Medical Center, and Tufts University School of Medicine, Boston, Mass 02111, USA
Circulation 105:2244-6. 2002
Advanced heart failure and transplant cardiology: a subspecialty is bornMarvin A Konstam
Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 53:834-6. 2009..In the years to come, the specialty must adapt to the ongoing rapid expansion of evidence-based knowledge in this field to continue to provide the highest level of care and the best outcomes to patients with heart failure...
Advanced heart failure and transplant cardiology: a subspecialty is bornMarvin A Konstam
Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts 02111, USA
J Card Fail 15:98-100. 2009..In the years to come, the specialty must adapt to the ongoing rapid expansion of evidence-based knowledge in this field to continue to provide the highest level of care and the best outcomes to patients with heart failure...
A cost-saving strategy for inpatient management of advanced decompensated heart failure patients: the Cardiomyopathy UnitDouglas Gregory
Cardiovascular Clinical Studies, Boston, MA 02111, USA
J Card Fail 15:428-34. 2009..This article analyzes the relative costs and revenues of the Tufts Medical Center Cardiomyopathy Unit (CMU), a recent innovation for grouping and managing advanced decompensated heart failure patients...
Prevention and reversal of left ventricular remodeling: summationMarvin A Konstam
Department of Medicine, Division of Cardiology, Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
J Card Fail 8:S506-11. 2002
Recent advances in the treatment of heart failureAyan R Patel
Division of Cardiology, New England Medical Center and Tufts University, Boston, Massachusetts 02111, USA
Circ J 66:117-21. 2002..As the importance of neurohormonal activation in the progression of heart failure becomes increasingly apparent, new therapeutic strategies targeting these neurohormonal systems are being investigated...
Noninvasive assessment of left ventricular remodeling: concepts, techniques, and implications for clinical trialsInder S Anand
Division of Cardiology, University of Minnesota Medical School and Veterans Administration Medical Center, Minneapolis, MN 55417, USA
J Card Fail 8:S452-64. 2002..CONCLUSIONS: Each of these techniques carries specific advantages and disadvantages for assessment of remodeling in individual patients and in the context of large-scale clinical trials...
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trialMarvin A Konstam
Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA
Lancet 374:1840-8. 2009..We compared the effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure...
Emerging ventricular assist devices for long-term cardiac supportRajan Krishnamani
The Cardiovascular Center, Tufts Medical Center, Boston, MA 02111, USA
Nat Rev Cardiol 7:71-6. 2010..These devices are at various stages of development and clinical investigation. One or more of these newer devices is likely to emerge as an important development in the treatment of patients with advanced heart failure...
Fatty infiltration of right ventricle (adipositas cordis): an unrecognized cause of early graft failure after cardiac transplantationRajan Krishnamani
Department of Medicine, Division of Cardiology, Tufts-New England Medical Center, Boston, MA 02111, USA
J Heart Lung Transplant 24:1143-5. 2005..If the diagnosis of fatty infiltration is suspected at time of donor harvest, the relative risks and benefits of proceeding with transplantation should be carefully assessed...
A multicenter randomized controlled evaluation of automated home monitoring and telephonic disease management in patients recently hospitalized for congestive heart failure: the SPAN-CHF II trialAndrew Weintraub
Division of Cardiology, Tufts Medical Center, Boston, MA, USA
J Card Fail 16:285-92. 2010..The AHM system measured and transmitted body weight, blood pressure, and heart rate data as well as subjective patient self-assessments via a standard telephone line to a central server...
Acute heart failure syndromes: current state and framework for future researchMihai Gheorghiade
Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Circulation 112:3958-68. 2005
Aligning quality and payment for heart failure care: defining the challengesEdward P Havranek
Division of Cardiology, Department of Medicine, Denver Health Medical Center and University of Colorado HSC, Denver, Colorado 80204-4507, USA
J Card Fail 9:251-4. 2003..This article describes each of these challenges in turn...
Influence of donor cocaine use on outcome after cardiac transplantation: analysis of the United Network for Organ Sharing Thoracic RegistryAndreas Brieke
Division of Cardiology, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA
J Heart Lung Transplant 27:1350-2. 2008....
Arginine vasopressin antagonists for the treatment of heart failure and hyponatremiaJohn J Finley
Division of Cardiology and Department of Medicine, Tufts Medical Center, Boston, Mass. 02111, USA
Circulation 118:410-21. 2008
Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysisJohn A TenBrook
Division of Clinical Decision Making, Informatics, and Telemedicine, Department of Medicine, Tufts-New England Medical Center, 750 Washington Street, Boston, MA 02111, USA
J Allergy Clin Immunol 113:977-82. 2004..However, the epidemiology of anaphylaxis and effects of beta-blocker therapy on anaphylaxis incidence and mortality require further study...
Novel neurohormonal antagonist strategies: vasopressin antagonism, anticytokine therapy, and endothelin antagonism in patients who have heart failureOlaf Hedrich
Tufts-New England Medical Center and Tufts University School of Medicine, Boston, MA 02111, USA
Heart Fail Clin 1:103-27. 2005
Reversal of left ventricular remodeling by pericardial tamponadePrem Soman
Division of Cardiology, Tufts-New England Medical Center, Boston, MA 02451, USA
J Card Fail 11:131-3. 2005
Transforming health care through the medical home: the example of heart failureMarvin A Konstam
The Cardiovascular Center, Tufts Medical Center, and Tufts University, Boston, MA 02111, USA
J Card Fail 15:736-8. 2009....
